Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Leukemia Research|December 3, 2014
Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemiaMichaela Liedtke, Tamara Dunn, Shira Dinner, et al.
International Journal of Hematology|August 26, 2016
Disease characteristics and prognosis of myelodysplastic syndrome presenting with isolated thrombocytopeniaJulie Waisbren, Shira Dinner, Jessica Altman, et al.
British Journal of Haematology|February 26, 2013
The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosisShira Dinner, Wesley Witteles, Ronald Witteles, et al.
British Journal of Haematology|April 5, 2016
A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myelomaTamara J Dunn, Shira Dinner, Elizabeth Price, et al.
International Journal of Hematology|May 27, 2018
A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myelomaShira Dinner, Tamara J Dunn, Elizabeth Price, et al.
Cancers|August 14, 2025
Ibrutinib in Combination with Lenalidomide Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma (AFT-15)Yvonne Efebera, Vera Suman, Shira Dinner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantationAndrew S Artz, Amittha Wickrema, Shira Dinner, et al.
Oncotarget|May 20, 2021
Inhibitory effects of Tomivosertib in acute myeloid leukemiaMilagros Suarez, Gavin T Blyth, Alain A Mina, et al.
Pediatric Blood & Cancer|May 10, 2025
Human-Centered Design of a Personalized Digital Health Intervention to Improve Oral Chemotherapy Adherence in Adolescents and Young Adults With Hematologic CancersAlexandra M Psihogios, Ayah El-Khatib, Kevin Matos, et al.
Leukemia|February 22, 2023
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Talha Badar, Ehab Atallah, Rory Shallis, et al.
Pageof 4